Tyson Bio AC500 Blood Glucose Monitoring System - Taiwan Registration c5658fee0dc153a5072161e3b161f882
Access comprehensive regulatory information for Tyson Bio AC500 Blood Glucose Monitoring System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c5658fee0dc153a5072161e3b161f882 and manufactured by TYSON BIORESEARCH INC.. The authorized representative in Taiwan is TYSON BIORESEARCH INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
c5658fee0dc153a5072161e3b161f882
Ministry of Health Medical Device Manufacturing No. 006287
Product Details
This product is intended for in vitro diagnostic use to measure microvascular whole blood glucose values on fingertips, palms or forearms, and is not suitable for neonatal diagnosis. Only applicable to personal blood glucose monitoring.
A Clinical chemistry and clinical toxicology
A1345 Glucose Test System
Produced in Taiwan, China
Dates and Status
Mar 26, 2019
Mar 26, 2029